Nuy Chau

632 total citations
15 papers, 506 citations indexed

About

Nuy Chau is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Nuy Chau has authored 15 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Nuy Chau's work include Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (4 papers) and Glycosylation and Glycoproteins Research (2 papers). Nuy Chau is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (4 papers) and Glycosylation and Glycoproteins Research (2 papers). Nuy Chau collaborates with scholars based in Australia, Thailand and United States. Nuy Chau's co-authors include John O. Miners, Aeneas Yeo, Peter Catcheside, Rajeev Ratnavadivel, Daniel Stadler, R. Doug McEvoy, Peter I. Mackenzie, Andrew Rowland, David J. Elliot and Kathleen Knights and has published in prestigious journals such as Journal of Biological Chemistry, Antimicrobial Agents and Chemotherapy and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Nuy Chau

15 papers receiving 490 citations

Peers

Countries citing papers authored by Nuy Chau

Since Specialization

Citations

This map shows the geographic impact of Nuy Chau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nuy Chau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nuy Chau more than expected).

Fields of papers citing papers by Nuy Chau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nuy Chau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nuy Chau. The network helps show where Nuy Chau may publish in the future.

Co-authorship network of co-authors of Nuy Chau

This figure shows the co-authorship network connecting the top 25 collaborators of Nuy Chau. A scholar is included among the top collaborators of Nuy Chau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nuy Chau. Nuy Chau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	The molecular basis of dapsone activation of CYP2C9-catalyzed nonsteroidal anti-inflammatory drug oxidation 2023 ·Journal of Biological Chemistry ·Pramod C. Nair, (unknown), Nuy Chau, Ross A. McKinnon, John O. Miners	2
2	Arginine-259 of UGT2B7 Confers UDP-Sugar Selectivity 2020 ·Molecular Pharmacology ·Pramod C. Nair, Nuy Chau, Ross A. McKinnon, John O. Miners	12
3	Scaling factors for the in vitro-in vivo extrapolation (IV-IVE) of renal drug and xenobiotic glucuronidation clearance. 2020 ·UNC Libraries ·John K. Fallon, Kathleen Knights, Philip C. Smith, (unknown), Nuy Chau, John O. Miners	2
4	Inhibition of human UDP-glucuronosyltransferase (UGT) enzymes by kinase inhibitors: Effects of dabrafenib, ibrutinib, nintedanib, trametinib and BIBF 1202 2019 ·Biochemical Pharmacology ·(unknown), Nuy Chau, Pramod C. Nair, Andrew Rowland, John O. Miners	25
5	Drug and Chemical Glucosidation by Control Supersomes and Membranes from Spodoptera frugiperda (Sf) 9 Cells: Implications for the Apparent Glucuronidation of Xenobiotics by UDP-glucuronosyltransferase 1A5 2018 ·Drug Metabolism and Disposition ·Nuy Chau, (unknown), Benjamin C. Lewis, Peter I. Mackenzie, John O. Miners	5
6	Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemia 2017 ·Biochemical Pharmacology ·John O. Miners, Nuy Chau, Andrew Rowland, (unknown), Ross A. McKinnon, Peter I. Mackenzie, Geoffrey T. Tucker, Kathleen Knights, Ganessan Kichenadasse	71
7	The human UDP-glucuronosyltransferase enzyme inhibition selectivity of nintedanib and its de-esterified metabolite BIBF1202 2017 ·Drug Metabolism and Pharmacokinetics ·(unknown), Andrew Rowland, (unknown), Nuy Chau, Peter I. Mackenzie, Kathleen Knights, John O. Miners	1
8	Scaling factors for thein vitro–in vivoextrapolation (IV–IVE) of renal drug and xenobiotic glucuronidation clearance 2016 ·British Journal of Clinical Pharmacology ·Kathleen Knights, (unknown), John K. Fallon, Nuy Chau, Philip C. Smith, John O. Miners	40
9	Inhibition of Human UDP-Glucuronosyltransferase Enzymes by Canagliflozin and Dapagliflozin: Implications for Drug-Drug Interactions 2015 ·Drug Metabolism and Disposition ·(unknown), Nuy Chau, Andrew Rowland, John O. Miners	37
10	Morphine Glucuronidation and Glucosidation Represent Complementary Metabolic Pathways That Are Both Catalyzed by UDP-Glucuronosyltransferase 2B7: Kinetic, Inhibition, and Molecular Modeling Studies 2014 ·Journal of Pharmacology and Experimental Therapeutics ·Nuy Chau, David J. Elliot, Benjamin C. Lewis, (unknown), Martin R. Johnston, Peter I. Mackenzie, John O. Miners	46
11	Effects of Ketamine on Human UDP-Glucuronosyltransferases In Vitro Predict Potential Drug-Drug Interactions Arising from Ketamine Inhibition of Codeine and Morphine Glucuronidation 2011 ·Drug Metabolism and Disposition ·Verawan Uchaipichat, Pritsana Raungrut, Nuy Chau, Benjamas Janchawee, Allan M. Evans, John O. Miners	35
12	The Novel UDP Glycosyltransferase 3A2: Cloning, Catalytic Properties, and Tissue Distribution 2010 ·Molecular Pharmacology ·Peter I. Mackenzie, (unknown), David J. Elliot, Nuy Chau, Julie-Ann Hulin, John O. Miners, Robyn Meech	60
13	Marked Reduction in Obstructive Sleep Apnea Severity in Slow Wave Sleep 2009 ·Journal of Clinical Sleep Medicine ·Rajeev Ratnavadivel, Nuy Chau, Daniel Stadler, Aeneas Yeo, R. Doug McEvoy, Peter Catcheside	150
14	Effects of furosemide, piretanide, and water loading on urinary excretion of cefazolin in humans 1984 ·Antimicrobial Agents and Chemotherapy ·(unknown), A Contrepois, Nuy Chau, (unknown), J. B. Fourtillan, C Carbon	5
15	Effects of phenylbutazone on extravascular diffusion, protein binding and urinary excretion of cefazolin in rabbits. 1981 ·Journal of Pharmacology and Experimental Therapeutics ·C Carbon, A Contrepois, Y. Nivoche, (unknown), (unknown), Nuy Chau	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact